FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)

UZ Leuven, Leuven

Seoul National University Hospital, Seoul

Hanyang University Seoul Hospital, Seoul

Hospital Universitari de Bellvitge, Barcelona

Kantonsspital St. Gallen, Sankt Gallen

Columbia University Medical Center, New York

Citta della Salute e della Scienza di Torino - Ospedale le Molinette, Torino

Taipei Veterans General Hospital (VGHTP), Taipei

Universitaetsmedizin Rostock, Rostock

Johns Hopkins University, Baltimore

The Ohio State University Wexner Medical Center, Columbus

Washington University School of Medicine, St Louis

University of Utah, Salt Lake City

Universitätsklinikum Ulm, Ulm

University of California San Diego, La Jolla

Stanford University Medical Center, Palo Alto

Massachusetts General Hospital, Boston

PSEG Centro de Pesquisa Clinica S.A., São Paulo

Montreal Neurological Institute, Montreal

St. James Hospital, Dublin

Toho University Omori Medical Center, Tokyo

Universitair Medisch Centrum Utrecht, Utrecht

Linden spólka z ograniczona odpowiedzialnoscia spólka komandytow, Krakow

University Hospital of Umea, Umeå

King's College Hospital, London